Favorable research funding sceanrio, increase in the demand for next-generation sequencing technique in cancer profiling and use of biomarkers in cancer profiling are driving the demand of the market.
Vancouver, BC -- (SBWIRE) -- 01/20/2021 -- With over 14 million new cases and over 8.2 million deaths in the United States, Cancer has been one of the leading socioeconomic pressures and the most prevalent cause of death worldwide, directly linked to complications caused by the disease. The WHO says the disease will lead to the deaths of over 11.5 million people across the globe by 2030.
The rise in the adoption of the cancer tumor profiling methods by oncologists is seen to drive the market because of the efficacy of cancer tumor profiling for diagnosis at the early stage of cancer, which is one factor in boosting the market growth. However, technical issues with sample collection and storage remain one of the factors that hinder the growth of the market for the forecast period.
Download Free Sample PDF Copy Of This Report at: https://www.emergenresearch.com/request-sample-form/50
Cancer Tumor Profiling Market: Drivers
In the next few years, the global market for cancer tumor profiling is expected to grow at a considerable rate, mainly due to increasing funding for activities aimed at improving the overall course of disease diagnosis and treatment and the vast technological developments recently observed in the field of cancer tumor profiling. The increasing acceptance of point-of-care diagnostics and the resulting increase in demand for customized medicines are also driving the market.
Key participants include: Caris Life Sciences, Foundation Medicine, GenomeDX, Genomic Health, Guardant Health, Helomics Corporation, HTG Molecular Diagnostics, Inc., Nanostring Technologies, Neogenomics Inc., Oxford Gene Technology, Qiagen N.V., Ribomed Biotechnologies Inc., among others.
The demand for cancer tumor profiling is also motivated by the continuously growing socioeconomic burden of cancer and the pressure on the healthcare industry to present successful methods of tackling and managing the disease.
Technique Type Outlook (Revenue, USD Billion; 2017-2027)
Genomics
Epigenetics
Metabolomics
Proteomics
Technology Outlook (Revenue, USD Billion; 2017-2027)
Immunoassays
In Situ Hybridization
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)
Microarray
Polymerase Chain Reaction (PCR)
Sequencing Technologies
Next Generation Sequencing(NGS)
Pyro Sequencing
Sanger Sequencing
Other Technologies
Application Outlook (Revenue, USD Billion; 2017-2027)
Research Application
Biomarker Discovery
Personalized Cancer Medicine
Clinical Application
Oncological Diagnostics
Prognostics
Monitoring and Treatment
Screening
Make an Enquiry for a Fast Response of Cancer Tumor Profiling Market Click https://www.emergenresearch.com/purchase-enquiry-form/50
Regional Outlook
More than 60% of the new cancer cases in the world are estimated to occur in regions, such as Asia, Africa, and South and Central America; 70% of cancer deaths in the world also occur in these regions. These regions may be the leading contributors to the growth and development of the global cancer tumor profiling industry, pointing to a large patient pool and potential customers. However, the market is currently driven by developed regions with high disposable incomes, such as North America and Europe.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cancer Tumor Profiling Market Segmentation & Impact Analysis
4.1. Cancer Tumor Profiling Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increase in the demand for next-generation sequencing technique in cancer profiling
4.2.2.2. Increase in the use of biomarkers in cancer profiling
4.2.2.3. Rise in incidence of cancer across the globe
4.2.2.4. Rise in the adoption of the cancer profiling methods by oncologists
4.2.3. Market restraints analysis
4.2.3.1. High capital investment
4.2.3.2. Technical issues with sample collection and storage
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Cancer Tumor Profiling Market By Technique Type Insights & Trends, Revenue (USD Million)
5.1. Technique Type Dynamics & Market Share, 2019 & 2027
5.1.1. Genomics
5.1.2. Epigenetics
5.1.3. Metabolomics
5.1.4. Proteomics
Chapter 6. Cancer Tumor Profiling Market By Technology Insights & Trends Revenue (USD Million)
6.1. Technology Dynamics & Market Share, 2019 & 2027
6.1.1. Immunoassays
6.1.2. In Situ Hybridization
6.1.2.1. Fluorescence In Situ Hybridization (FISH)
6.1.2.2. Chromogenic In Situ Hybridization (CISH)
6.1.3. Microarray
6.1.4. Polymerase Chain Reaction (PCR)
6.1.5. Sequencing Technologies
6.1.5.1. Next Generation Sequencing(NGS)
6.1.5.2. Pyro Sequencing
6.1.5.3. Sanger Sequencing
6.1.6. Other Technologies
To Be Continued…!
Get Access to Full summary of this report @ https://www.emergenresearch.com/industry-report/cancer-tumor-profiling-market
Take a Look at our Related Reports:
Automotive MEMS Sensor Market Size To Be Worth USD 4.84 Billion by 2027 | Emergen Research
Mobile C-Arms Market To Be Worth USD 1.61 Billion By 2027 Growing at a CAGR of 5.2% | Emergen Research
Mobility as a Service Market Size Worth USD 523.61 Billion by 2027 | Emergen Research
Counter UAS Market To Reach USD 4.70 Billion By 2027 Growing at a CAGR of 26.8% | Emergen Research
Gallium Nitride Market Size To Be Worth USD 320.4 Million by 2027 Growing at a CAGR of 20.8%| Emergen Research
Thermoelectric Materials Market Size Worth USD 96.2 Million by 2027 | Emergen Research
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs